New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 21, 2014
07:01 EDTINSYInsys Therapeutics reports dismissal of stockholder class action lawsuit
Insys Therapeutics announced that the previously reported stockholder class action lawsuit that had been filed against the company and certain of its officers and directors in U.S. District Court for the District of Arizona was on February 20, voluntarily dismissed by the plaintiff and thereafter terminated by the court. No payment or consideration of any kind was made by any of the defendants in connection with the dismissal.
News For INSY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 28, 2014
06:47 EDTINSYInsys paid doctors with troubled pasts to market drug, NY Times reports
Five of the 20 physicians who received the most money from Insys Therapeutics to promote its painkiller drug Subsys recently faced legal or disciplinary action, New York Times reports, citing an analysis of the federal Open Payments database. Reference Link
November 24, 2014
07:04 EDTINSYInsys Therapeutics receives FDA orphan drug designation to CBD candidate
Insys Therapeutics announced that the FDA has granted orphan drug designation, or ODD, to its pharmaceutical cannabidiol, or CBD, candidate for the treatment of pediatric schizophrenia. This marks the fifth ODD for the company's CBD program.
November 19, 2014
12:04 EDTINSYInsys Therapeutics cannabidiol receives FDA orphan designation
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use